Biochemistry and molecular biology

Over 90 percent of the human cutaneous virome is made up of unclassifiable “dark matter”

Physical activity is an important preanalytical variable in blood analysis and here’s why.

Molecular techniques can offer rapid, accurate diagnosis of lung infections in cystic fibrosis, but most labs feel the technologies are out of reach. What if there was an affordable alternative?

New technologies and molecular discoveries are changing the way diagnoses are made. But how will already burdened molecular pathology labs cope with more cases and restricted budgets?

Why we need to harmonize fasting definitions for blood sampling

Gene expression panel could help breast cancer patients with a low risk of recurrence avoid unnecessary chemotherapy

Keith Miller is Director and co-founder of CADQAS (Cancer Diagnostic Quality Assurance Services), a not-for-profit community interest company hosted by Poundbury Cancer Institute (PCI).

Christopher Hudson is Director of Tissue Diagnostics UK and Ireland at Roche, the multinational life sciences company that supports the Poundbury Cancer Institute through funding and research collaboration.

A new device, the Cytosponge, could pair with biomarker testing to offer an effective, low-cost way to diagnose and stratify Barrett’s esophagus

Tumor-activated DNA minicircles offer a potential solution for cancer detection, treatment, or both.